Healthcare

Healthcare combines structural demand with very different risk profiles: recurring software and diagnostics, procedure growth, drug pipelines, and payer economics.

CompanyWhy it mattersSignal

LLY

Eli Lilly

Obesity and diabetes

Obesity and diabetes drugs, especially the GLP-1 franchise, expand into a huge metabolic-health market.

Strong · 76.8

$1,233.66

−1.06%

DXCM

Dexcom

Metabolic monitoring

Continuous glucose monitoring expands beyond insulin users and into metabolic health.

Strong · 78.1

$89.16

−2.09%

VEEV

Veeva Systems

Life-sciences software

Life-sciences software benefits from digitized trials, compliance, and AI workflows.

Solid · 72.3

$246.75

−0.69%

ISRG

Intuitive Surgical

Robotic surgery

Robotic surgery adoption increases procedure volume and recurring instrument revenue.

Solid · 66.2

$371.72

−0.50%

6 more names and their full research context are available with Pro.

Resources for deeper research

The Peter Attia Drive ↗STAT ↗BioCentury ↗The Readout LO ↗

Curated research map · research only, not investment advice.